• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Digital Diabetes Management Market

    ID: MRFR/HC/18078-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Digital Diabetes Management Market Research Report By Technology (Mobile Applications, Wearable Devices, Remote Monitoring Solutions, Telehealth Services), By Product Type (Blood Glucose Monitors, Insulin Delivery Devices, Continuous Glucose Monitoring Systems, Diabetes Management Software), By End User (Patients, Healthcare Professionals, Pharmacies, Diabetes Care Centers) and By Functionality (Data Management, Patient Engagement, Clinical Decision Support, Remote Patient Monitoring) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Digital Diabetes Management Market Infographic
    Purchase Options

    US Digital Diabetes Management Market Summary

    As per MRFR analysis, the US digital diabetes-management market size was estimated at 950.0 USD Million in 2024. The US digital diabetes-management market is projected to grow from 1069.51 USD Million in 2025 to 3499.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 12.58% during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The US digital diabetes-management market is experiencing robust growth driven by technological advancements and increasing demand for personalized healthcare solutions.

    • The rise of mobile health applications is transforming diabetes management by enhancing patient engagement and self-monitoring capabilities.
    • Integration of wearable technology is becoming prevalent, allowing for real-time health data collection and analysis.
    • Telehealth services are expanding, providing patients with convenient access to healthcare professionals and support.
    • The increasing prevalence of diabetes and technological advancements in health monitoring are key drivers propelling market growth.

    Market Size & Forecast

    2024 Market Size 950.0 (USD Million)
    2035 Market Size 3499.0 (USD Million)

    Major Players

    Abbott (US), Medtronic (US), Roche (CH), Dexcom (US), Ascensia Diabetes Care (DE), Insulet Corporation (US), Tandem Diabetes Care (US), Glooko (US)

    US Digital Diabetes Management Market Trends

    The digital diabetes-management market is currently experiencing a notable transformation, driven by advancements in technology and an increasing emphasis on personalized healthcare. As more individuals seek effective ways to manage their diabetes, the integration of mobile applications, wearable devices, and telehealth services has become increasingly prevalent. These innovations not only facilitate real-time monitoring of blood glucose levels but also empower patients to take charge of their health through data-driven insights. Furthermore, the growing awareness of diabetes-related complications has prompted healthcare providers to adopt digital solutions that enhance patient engagement and adherence to treatment plans. In addition, the digital diabetes-management market is likely to benefit from ongoing collaborations between technology companies and healthcare organizations. Such partnerships may lead to the development of more sophisticated tools that cater to the unique needs of diabetic patients. Moreover, regulatory support for digital health initiatives appears to be strengthening, which could further accelerate the adoption of these technologies. As the landscape evolves, it seems essential for stakeholders to remain attuned to emerging trends and consumer preferences, ensuring that solutions are not only effective but also user-friendly and accessible to a diverse population.

    Rise of Mobile Health Applications

    Mobile health applications are becoming increasingly popular among individuals managing diabetes. These apps offer features such as blood glucose tracking, meal planning, and medication reminders, which help users maintain better control over their condition. The convenience of having these tools readily available on smartphones encourages more proactive health management.

    Integration of Wearable Technology

    Wearable devices are gaining traction in the digital diabetes-management market, providing users with continuous monitoring capabilities. These devices can track vital health metrics, such as glucose levels and physical activity, allowing for real-time feedback. This integration supports users in making informed decisions about their health and lifestyle.

    Telehealth Services Expansion

    The expansion of telehealth services is reshaping how diabetes care is delivered. Patients can now consult healthcare professionals remotely, reducing barriers to access and improving convenience. This trend is particularly beneficial for those in rural areas or with mobility challenges, as it ensures that they receive timely support and guidance.

    US Digital Diabetes Management Market Drivers

    Increasing Prevalence of Diabetes

    The rising incidence of diabetes in the US is a primary driver for the digital diabetes-management market. According to the Centers for Disease Control and Prevention (CDC), approximately 34.2 million Americans, or 10.5% of the population, have diabetes. This alarming statistic underscores the urgent need for effective management solutions. As the number of diagnosed cases continues to grow, the demand for digital tools that facilitate monitoring and management of diabetes is likely to increase. The digital diabetes-management market is expected to expand as healthcare providers and patients seek innovative solutions to improve health outcomes and reduce complications associated with diabetes. This trend suggests a robust market potential for digital health technologies that can assist in daily management and provide real-time data to both patients and healthcare professionals.

    Technological Advancements in Health Monitoring

    Technological innovations play a crucial role in shaping the digital diabetes-management market. The development of advanced health monitoring devices, such as continuous glucose monitors (CGMs) and insulin delivery systems, has transformed diabetes care. These devices enable patients to track their glucose levels in real-time, leading to more informed decision-making regarding their health. The integration of artificial intelligence (AI) and machine learning into these technologies further enhances their capabilities, allowing for personalized treatment plans. As these technologies become more accessible and affordable, the digital diabetes-management market is poised for growth. The increasing adoption of smart devices and applications that facilitate data sharing between patients and healthcare providers indicates a shift towards more proactive diabetes management.

    Growing Demand for Personalized Healthcare Solutions

    The digital diabetes-management market is significantly influenced by the increasing demand for personalized healthcare solutions. Patients are increasingly seeking tailored approaches to their diabetes management, which can be facilitated through digital platforms. These platforms often utilize data analytics to provide customized recommendations based on individual health metrics. The trend towards personalized medicine is supported by a growing body of evidence suggesting that individualized treatment plans can lead to better health outcomes. As healthcare systems in the US continue to evolve, the integration of personalized digital solutions is likely to become a standard practice. This shift not only enhances patient engagement but also fosters a more collaborative relationship between patients and healthcare providers, driving growth in the digital diabetes-management market.

    Rising Healthcare Costs and Focus on Cost-Effectiveness

    The escalating costs associated with diabetes care are a significant driver for the digital diabetes-management market. The American Diabetes Association estimates that the total cost of diagnosed diabetes in the US was $327 billion in 2017, a figure that has likely increased. As healthcare costs continue to rise, both patients and providers are seeking cost-effective solutions to manage diabetes. Digital tools that offer remote monitoring and telehealth services can reduce the need for frequent in-person visits, thereby lowering overall healthcare expenses. This focus on cost-effectiveness is likely to propel the adoption of digital diabetes-management solutions, as they provide a means to improve care while managing financial burdens. The market is expected to benefit from this trend as stakeholders prioritize solutions that deliver value without compromising quality.

    Increased Awareness and Education on Diabetes Management

    There is a growing awareness and education regarding diabetes management among the US population, which serves as a catalyst for the digital diabetes-management market. Public health campaigns and educational initiatives have significantly improved understanding of diabetes and its complications. As individuals become more informed about the importance of effective management, they are more likely to seek out digital solutions that can assist them in their daily lives. This heightened awareness is fostering a culture of proactive health management, where patients actively engage with digital tools to monitor their condition. Consequently, the digital diabetes-management market is likely to experience growth as more individuals recognize the benefits of utilizing technology in their diabetes care.

    Market Segment Insights

    By Technology: Glucose Monitoring Devices (Largest) vs. Diabetes Management Software (Fastest-Growing)

    In the US digital diabetes-management market, the distribution of market share among segment values reveals a strong preference for Glucose Monitoring Devices, which command the largest share due to their critical role in daily diabetes management. Insulin Delivery Devices and Diabetes Management Software also hold significant positions, demonstrating the diverse needs of diabetes patients. Mobile Applications are capturing an increasing share as more users seek mobile solutions for health management. Growth trends within this segment are driven by technological advancements, including the integration of artificial intelligence in devices and software. The increasing prevalence of diabetes in the US is fostering demand for innovative solutions. Additionally, the rise of telehealth services is accelerating the adoption of digital diabetes management tools, particularly diabetes management software and mobile applications, which are becoming essential components of comprehensive care strategies.

    Glucose Monitoring Devices (Dominant) vs. Diabetes Management Software (Emerging)

    Glucose Monitoring Devices have established themselves as the dominant segment within the US digital diabetes-management market, primarily due to their vital role in enabling real-time blood sugar monitoring for patients. These devices consist of continuous glucose monitors (CGMs) and traditional fingerstick meters, offering varied functionalities to suit different lifestyle preferences and needs. On the other hand, Diabetes Management Software has emerged as a crucial tool for comprehensive diabetes care, leveraging data analytics and patient management features to enhance treatment outcomes. These software solutions are increasingly popular among healthcare providers and patients for their ability to track and analyze health metrics, providing tailored insights and prompting timely interventions. As these technologies evolve, they present opportunities for improved patient engagement and better health management.

    By Product Type: Continuous Glucose Monitors (Largest) vs. Smart Insulin Pens (Fastest-Growing)

    In the US digital diabetes-management market, Continuous Glucose Monitors hold the largest share, driven by their ability to provide real-time glucose monitoring with minimal need for finger pricks. They are favored for their convenience and long-term health benefits, appealing to a broad range of diabetes patients. Smart Insulin Pens also show significant traction, gaining a notable market share as they offer precision and ease of insulin administration, which is changing the management landscape for Type 1 and Type 2 diabetes patients. The growth of this segment is propelled by technological advancements and an increasing awareness of diabetes management options. As consumers become more health-conscious and seek to leverage technology for better health outcomes, both Continuous Glucose Monitors and Smart Insulin Pens are expected to thrive. Additionally, supportive healthcare policies and rising incidences of diabetes contribute to the upward trend, creating a favorable environment for continuous innovation and product launches within the sector.

    Continuous Glucose Monitors (Dominant) vs. Smart Insulin Pens (Emerging)

    Continuous Glucose Monitors are characterized by their ability to deliver continuous readings of glucose levels, which empowers users to make informed decisions regarding their insulin and lifestyle. This dominance is supported by robust clinical studies showcasing improved glycemic control. On the other hand, Smart Insulin Pens are emerging as flexible tools that cater to personalized insulin delivery, coupled with digital tracking capabilities that enhance patient engagement. While Continuous Glucose Monitors are preferred for their comprehensive monitoring system, Smart Insulin Pens are carving a niche by integrating with diabetes management apps, thus offering a new dimension in the diabetes care continuum. Together, these products signify a transformation in patient-centric diabetes management.

    By End User: Individuals (Largest) vs. Healthcare Providers (Fastest-Growing)

    In the US digital diabetes-management market, the distribution of market share among end users showcases that individuals represent the largest segment. They leverage various digital tools for daily management of diabetes, contributing significantly to the market's growth. Healthcare providers, while smaller in comparison, are rapidly adopting digital solutions to enhance patient care, thus positioning themselves as a vital segment in the evolving marketplace. The growth trends indicate that the individual segment continues to expand at a robust pace, driven by increasing awareness and accessibility of technology. Meanwhile, healthcare providers are embracing digital platforms to improve care delivery, making them the fastest-growing segment. The rise in telehealth services and integration of data analytics are propelling this growth, as both individuals and healthcare entities aim for more efficient diabetes management solutions.

    Individuals: Dominant vs. Healthcare Providers: Emerging

    Individuals in the US digital diabetes-management market are characterized by their reliance on mobile applications and wearables that enable better self-monitoring and management of their condition. This segment's dominance is driven by a growing population of diabetes patients seeking user-friendly solutions that offer real-time data and personalized feedback. Conversely, healthcare providers represent an emerging segment, focusing on integrating digital diabetes solutions into clinical practice. With the shift towards patient-centered care, healthcare providers are beginning to realize the benefits of incorporating digital tools, which enhance their ability to deliver tailored treatment plans while improving patient engagement and outcomes.

    By Distribution Channel: Online Sales (Largest) vs. Pharmacies (Fastest-Growing)

    In the US digital diabetes-management market, the distribution of sales across various channels showcases a dynamic landscape. Online sales have emerged as the largest channel, reflecting a shift towards digital solutions and the convenience they offer. Pharmacies, while traditionally a strong channel, are experiencing significant growth due to increasing integration with health technologies and direct-to-consumer models, making them a crucial player in the market. Growth trends indicate a robust increase in online sales driven by consumer preferences for digital management tools and the convenience of purchasing from home. Pharmacies are evolving rapidly, leveraging technology to offer integrated diabetes management solutions and personalized care, thus positioning themselves favorably for future expansion. This competitive landscape suggests a shift in how patients access diabetes management resources, marking a significant trend in the market.

    Online Sales (Dominant) vs. Pharmacies (Emerging)

    Online sales in the US digital diabetes-management market have become the dominant channel, characterized by their user-friendly interfaces, broad accessibility, and extensive product offerings tailored for diabetes management. Consumers appreciate the convenience of ordering supplies and receiving educational resources online. On the other hand, pharmacies represent an emerging channel, steadily adapting to the evolving market landscape by incorporating technology into their services. They not only provide essential medications but also engage in patient education and support services, enhancing the overall diabetes management experience. This duality between the dominance of online sales and the emerging role of pharmacies highlights the diverse approaches to diabetes care, where technology and personal touch can coexist to improve health outcomes.

    Get more detailed insights about US Digital Diabetes Management Market

    Key Players and Competitive Insights

    The digital diabetes-management market is characterized by a rapidly evolving competitive landscape, driven by technological advancements and increasing demand for personalized healthcare solutions. Key players such as Abbott (US), Medtronic (US), and Dexcom (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Abbott (US) focuses on continuous glucose monitoring (CGM) systems, emphasizing user-friendly interfaces and integration with mobile applications. Medtronic (US) is enhancing its insulin delivery systems, aiming for seamless connectivity with digital health platforms. Dexcom (US) is expanding its CGM offerings, particularly in the realm of data analytics, which appears to be a critical differentiator in the market.

    The business tactics employed by these companies include localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of fluctuating global trade dynamics. The market structure is moderately fragmented, with a mix of established players and emerging startups. This fragmentation allows for diverse product offerings, yet the collective influence of major companies shapes competitive dynamics significantly, as they set benchmarks for innovation and customer engagement.

    In October 2025, Abbott (US) announced the launch of its latest CGM system, which integrates advanced AI algorithms to provide real-time glucose predictions. This strategic move not only enhances user experience but also positions Abbott as a leader in predictive analytics within diabetes management. The integration of AI is likely to attract tech-savvy consumers who prioritize data-driven health management.

    In September 2025, Medtronic (US) unveiled a new partnership with a leading telehealth provider to enhance remote patient monitoring capabilities. This collaboration is strategically significant as it aligns with the growing trend of telehealth services, allowing Medtronic to expand its reach and improve patient outcomes through continuous engagement. Such partnerships may redefine how diabetes care is delivered, emphasizing convenience and accessibility.

    In August 2025, Dexcom (US) expanded its data-sharing capabilities by integrating with popular health apps, thereby enhancing user engagement and fostering a community of support among diabetes patients. This strategic action reflects a broader trend towards interoperability in health technology, which is essential for creating a holistic diabetes management ecosystem. By facilitating data exchange, Dexcom strengthens its position as a pivotal player in the digital health landscape.

    As of November 2025, current competitive trends in the digital diabetes-management market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based strategies to a focus on technological innovation, enhanced user experiences, and reliable supply chains. This shift underscores the importance of adaptability and forward-thinking in maintaining a competitive edge in a dynamic market.

    Key Companies in the US Digital Diabetes Management Market market include

    Industry Developments

    In recent months, the US Digital Diabetes Management Market has witnessed notable advancements and developments. Companies such as Glooko, Dexcom, and Omada Health continue to innovate in digital health solutions, focusing on enhancing user engagement and diabetes management outcomes.

    Medtronic has been expanding its integrated diabetes management systems, improving patient accessibility and connectivity. Notably, in September 2023, Abbott Laboratories announced the launch of a new smart glucose monitoring device aimed at enhancing user experience and data sharing globally.

    Additionally, in August 2023, Livongo Health and WellDoc teamed up to enhance digital behavioral strategies for chronic condition management, signaling a strategic collaboration to broaden their service offerings. Furthermore, the market shows consistent growth trajectories, with companies such as Bigfoot Biomedical reporting significant increases in market valuations.

    This growth reflects a heightened demand for technology-driven diabetes solutions amid rising diabetes prevalence in the United States. Recent events within the past two years also include collaborations between Novo Nordisk and MySugr aimed at integrating data into personalized treatment plans, reflecting the sector's combined efforts toward improving patient outcomes through digital transformation in chronic disease management.

    Future Outlook

    US Digital Diabetes Management Market Future Outlook

    The digital diabetes-management market is projected to grow at a 12.58% CAGR from 2024 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising demand for personalized healthcare solutions.

    New opportunities lie in:

    • Development of AI-driven predictive analytics tools for patient management.
    • Expansion of telehealth services tailored for diabetes care.
    • Integration of wearable devices with real-time data sharing capabilities.

    By 2035, the market is expected to be robust, driven by innovation and increased consumer engagement.

    Market Segmentation

    US Digital Diabetes Management Market End User Outlook

    • Individuals
    • Healthcare Providers
    • Pharmaceutical Companies
    • Research Organizations

    US Digital Diabetes Management Market Technology Outlook

    • Glucose Monitoring Devices
    • Insulin Delivery Devices
    • Diabetes Management Software
    • Mobile Applications

    US Digital Diabetes Management Market Product Type Outlook

    • Continuous Glucose Monitors
    • Smart Insulin Pens
    • Diabetes Management Platforms
    • Wearable Devices

    US Digital Diabetes Management Market Distribution Channel Outlook

    • Online Sales
    • Pharmacies
    • Hospitals
    • Specialized Diabetes Clinics

    Report Scope

    MARKET SIZE 2024 950.0(USD Million)
    MARKET SIZE 2025 1069.51(USD Million)
    MARKET SIZE 2035 3499.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 12.58% (2024 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019 - 2024
    Market Forecast Units USD Million
    Key Companies Profiled Abbott (US), Medtronic (US), Roche (CH), Dexcom (US), Ascensia Diabetes Care (DE), Insulet Corporation (US), Tandem Diabetes Care (US), Glooko (US)
    Segments Covered Technology, Product Type, End User, Distribution Channel
    Key Market Opportunities Integration of artificial intelligence in digital diabetes-management market enhances personalized patient care and treatment outcomes.
    Key Market Dynamics Rising consumer demand for personalized digital solutions drives innovation in diabetes management technologies.
    Countries Covered US

    Leave a Comment

    FAQs

    What is the expected market size for the US Digital Diabetes Management market in 2024?

    The US Digital Diabetes Management market is expected to be valued at 2.16 billion USD in 2024.

    What will be the projected value of the US Digital Diabetes Management market by 2035?

    The projected value of the US Digital Diabetes Management market is anticipated to reach 12.36 billion USD by 2035.

    What is the expected compound annual growth rate (CAGR) for the US Digital Diabetes Management market from 2025 to 2035?

    The US Digital Diabetes Management market is expected to grow at a CAGR of 17.199 percent from 2025 to 2035.

    Which segment of the US Digital Diabetes Management market is anticipated to lead in market size by 2035?

    By 2035, mobile applications are projected to lead the market with a size of 4.5 billion USD.

    What are the anticipated market values for wearable devices in the US Digital Diabetes Management market by 2035?

    The market value for wearable devices in the US Digital Diabetes Management sector is expected to reach 2.8 billion USD by 2035.

    Who are the key players in the US Digital Diabetes Management market?

    Key players in the US Digital Diabetes Management market include Glooko, Bigfoot Biomedical, Omada Health, and Medtronic among others.

    What will be the value of remote monitoring solutions in the US Digital Diabetes Management market by 2035?

    Remote monitoring solutions are projected to hold a market value of 2.5 billion USD in the US Digital Diabetes Management market by 2035.

    What is the expected market size for telehealth services in the US Digital Diabetes Management market by 2035?

    Telehealth services are expected to reach a market size of 2.56 billion USD in the US Digital Diabetes Management market by 2035.

    How is the growth rate characterized for the US Digital Diabetes Management market?

    The growth rate for the US Digital Diabetes Management market is characterized by a robust and increasing trend driven by technology advancements.

    What are the major growth drivers for the US Digital Diabetes Management market?

    Major growth drivers for the US Digital Diabetes Management market include increasing prevalence of diabetes and advancements in digital health technologies.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions